NCT05787951

Brief Summary

  1. 1.to assess the frequency of acute myeloid leukemia at clinical Haematology unit of Assiute university hospital
  2. 2.to study correlations of known risk factors and if there are new risk factors participate in increasing frequency of acute myeloid leukemia

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 28, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

2 years

First QC Date

March 15, 2023

Last Update Submit

March 15, 2023

Conditions

Myeloid Leukemia

Outcome Measures

Primary Outcomes (1)

  • Frequency of acute myeloid leukemia at clinical Haemtology unit of Assiute university hospital

    Two years

Secondary Outcomes (1)

  • Risk factors of acute myeloid leukemia at clinical Haemtology unit of Assiute university hospital

    Two years

Interventions

Bone marrow aspirite for diagnosisDIAGNOSTIC_TEST

Routine investigation of acute myeloid leukemia such as bone marrow aspirite for diagnosis ,cbc

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult Patients(above 18 years) diagnosed as acute myeloid leukemia according to WHO diagnostic criteria

You may qualify if:

  • Adult Patients(above 18 years) diagnosed as acute myeloid leukemia according to WHO diagnostic criteria

You may not qualify if:

  • Patients with other types of leukemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hwang SM. Classification of acute myeloid leukemia. Blood Res. 2020 Jul 31;55(S1):S1-S4. doi: 10.5045/br.2020.S001.

    PMID: 32719169BACKGROUND

MeSH Terms

Conditions

Leukemia, Myeloid

Interventions

Diagnosis

Condition Hierarchy (Ancestors)

LeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Central Study Contacts

Sanaa Hussien

CONTACT

00201023127310Sanaaezzate212@gmail.com

Osama Ibrahim

CONTACT

Oibrahiem@yahoo.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sanaa Ezzat Hussien

Study Record Dates

First Submitted

March 15, 2023

First Posted

March 28, 2023

Study Start

May 1, 2023

Primary Completion

May 1, 2025

Study Completion

August 1, 2025

Last Updated

March 28, 2023

Record last verified: 2023-03